0.05Open0.05Pre Close0 Volume2 Open Interest14.00Strike Price0.00Turnover211.40%IV81.99%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0522Delta0.0417Gamma154.40Leverage Ratio-0.0143Theta0.0001Rho8.06Eff Leverage0.0013Vega
SIGA Technologies Stock Discussion
SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies
SIGA Technologies (NASDAQ: SIGA) has entered into an exclusive license agreement with Vanderbilt University for a portfolio of preclinical fully human monoclonal antibodies (mAbs). These mAbs have potential as treatments for a broad range of orthopoxviruses, including smallpox and mpox. The agreement grants SIGA exclusive rights to develop, manufacture...
SIGA Technologies Inc - Contract in Response to Morocco Ministry of Health Request. Makes first commercial sale in Africa
SIGA Announces Agreement to Supply TPOXX® in Morocco
wow, finally increasing a little... wondering if it's best to wait for before earnings report to buy in
https://www.msn.com/en-us/health/other/la-county-mpox-cases-are-rising-what-s-driving-the-increase/ar-AA1rbgw4?ocid=msedgdhp&pc=U531&cvid=3d9cefae83aa481fa5b56d8a24ecd771&ei=18
No comment yet